Have a feature idea you'd love to see implemented?
Let us know!
ZYXI Zynex Inc
Price (delayed)
$7.83
Market cap
$248.54M
P/E Ratio
46.06
Dividend/share
N/A
EPS
$0.17
Enterprise value
$292.21M
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery
Highlights
Zynex's revenue has increased by 9% YoY and by 2.6% from the previous quarter
The gross profit has grown by 9% YoY and by 2.8% from the previous quarter
ZYXI's quick ratio has shrunk by 54% YoY but it is up by 11% QoQ
Zynex's net income has plunged by 65% YoY and by 26% from the previous quarter
The EPS has plunged by 62% YoY and by 23% from the previous quarter
Key stats
What are the main financial stats of ZYXI
Market
Valuations
Earnings
Shares outstanding
31.74M
Market cap
$248.54M
Enterprise value
$292.21M
Price to earnings (P/E)
46.06
Price to book (P/B)
7.58
Price to sales (P/S)
1.28
EV/EBIT
28.25
EV/EBITDA
18.87
EV/Sales
1.51
Revenue
$193.61M
EBIT
$10.34M
EBITDA
$15.49M
Free cash flow
$17.22M
Per share
Balance sheet
Liquidity
EPS
$0.17
Free cash flow per share
$0.54
Book value per share
$1.03
Revenue per share
$6.1
TBVPS
$2.95
Total assets
$121.92M
Total liabilities
$89.1M
Debt
$74.97M
Equity
$32.82M
Working capital
$55.88M
Debt to equity
2.28
Current ratio
4.06
Quick ratio
3.01
Net debt/EBITDA
2.82
Margins
Efficiency
Dividend
EBITDA margin
8%
Gross margin
79.8%
Net margin
3.1%
Operating margin
5.4%
Return on assets
4.5%
Return on equity
14.2%
Return on invested capital
8.4%
Return on capital employed
10%
Return on sales
5.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZYXI stock price
How has the Zynex stock price performed over time
Intraday
-1.51%
1 week
-5.21%
1 month
-0.76%
1 year
-2.37%
YTD
-28.1%
QTD
-4.04%
Financial performance
How have Zynex's revenue and profit performed over time
Revenue
$193.61M
Gross profit
$154.52M
Operating income
$10.53M
Net income
$6.04M
Gross margin
79.8%
Net margin
3.1%
The net margin has plunged by 68% YoY and by 28% from the previous quarter
Zynex's net income has plunged by 65% YoY and by 26% from the previous quarter
Zynex's operating margin has shrunk by 51% YoY and by 7% QoQ
The company's operating income fell by 46% YoY and by 4.4% QoQ
Growth
What is Zynex's growth rate over time
Valuation
What is Zynex stock price valuation
P/E
46.06
P/B
7.58
P/S
1.28
EV/EBIT
28.25
EV/EBITDA
18.87
EV/Sales
1.51
The EPS has plunged by 62% YoY and by 23% from the previous quarter
The P/E is 8% above the last 4 quarters average of 42.6 and 8% above the 5-year quarterly average of 42.7
The equity has declined by 47% year-on-year
The P/B is 18% less than the 5-year quarterly average of 9.2 and 11% less than the last 4 quarters average of 8.5
The price to sales (P/S) is 70% lower than the 5-year quarterly average of 4.2 and 29% lower than the last 4 quarters average of 1.8
Zynex's revenue has increased by 9% YoY and by 2.6% from the previous quarter
Efficiency
How efficient is Zynex business performance
The ROIC has plunged by 69% YoY and by 17% from the previous quarter
ZYXI's ROA has dropped by 68% year-on-year and by 22% since the previous quarter
The ROS has plunged by 58% YoY and by 20% from the previous quarter
ZYXI's ROE is down by 47% year-on-year and by 13% since the previous quarter
Dividends
What is ZYXI's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Zynex financials performed over time
The total assets is 37% more than the total liabilities
ZYXI's quick ratio has shrunk by 54% YoY but it is up by 11% QoQ
ZYXI's current ratio is down by 47% YoY but it is up by 13% from the previous quarter
The debt is 128% more than the equity
Zynex's debt to equity has soared by 98% YoY
The equity has declined by 47% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.